The energy complex is screaming shortage — Bloomberg reports oil, gas and diesel are all surging and pointing toward a winter crisis that is forcing central banks to reassess policy. Every dollar higher in fossil fuel prices strengthens the economic case

Verdict: the nuclear story has one earner worth owning — wait for the reclaim

The strongest point for this idea is Cameco: FY2025 shows the margin inflection the nuclear thesis predicts — net margin up 11.45 points to 16.9%, free cash flow of $1.08B (the 94.8th percentile of materials peers), and a dividend raised 50.9% to $0.172 per share. The strongest point against is the trade's own track record: the completed 12-month backtest traded twice, won nothing, and lost 21.9% with a 23.5% drawdown, while NuScale's Q2 2026 gross margin collapsed to about -202.7% and insiders at Oklo and NuScale filed net open-market selling of roughly $12.5M and $0.75M respectively for the quarter ended June 30, 2026 (a delayed filing, not fresh selling). Nothing triggers today — CCJ at $96.68 sits below its 20-day average with RSI at 44.8, and OKLO, SMR and URA fail three entry conditions each. The verdict would flip if CCJ confirms a close back above its 20-day average ($97.18) with RSI above 50 and MACD positive in a single daily bar, or if the next insider filings show net buying. Our conviction breakdown: thesis support 60, trade readiness 30, risk quality 40, backtest evidence 25, fundamentals trend 55.

Trade now: wait for the reclaim — no entry is live on any of the four names

Nothing triggers today. The setup is a pullback-and-reclaim long on each name: the daily low must touch or break the lower Bollinger Band (20), and then price must close back above the 20-day average, with the 14-day RSI above 50 and a positive MACD histogram — all four at once. **CCJ** is closest: at $96.68 it is already at or below the lower band ($97.62) and the MACD histogram is positive (1.26), but the close sits $0.50 *below* its 20-day average ($97.18) and RSI is 44.8, needing a climb of over 5 points to clear 50. **OKLO** ($36.22) and **SMR** ($8.61) are at or below their bands but fail three conditions each — RSI is 31.9 and 35.9 respectively, both below their 20-day averages, and OKLO's MACD is negative. **URA** ($43.53) passes the band and MACD tests but sits $1.72 under its 20-day average with RSI at 37.2. "Wait" here means: place alerts at each 20-day average and the RSI-50 line, and do nothing until a single daily bar satisfies all four conditions on one symbol. Risk framing once an entry fires: the stop is a daily close back below the reclaimed 20-day average — a dynamic level, roughly 0.5% beneath CCJ's current price and 14% below OKLO's — and the profit trigger is the 14-day RSI reaching 70, with a hard time exit at 60 trading days. Because the stop and target are both indicator-driven, the reward:risk cannot be quoted as a fixed price ratio today; it tightens or widens with the moving average each session. One honesty note on the evidence: the completed 12-month backtest on the CCJ leg traded twice and lost money both times (roughly -21.9% total, -23.5% peak-to-trough). That is a reason to respect the entry filter rather than pre-position — the strategy is designed to buy reclaims, not falling knives, and jumping in early is exactly the trade the rules refuse. Position sizing caps any single name at 25% of the book with about 2.4% account risk per trade.

A Supply Shock Nuclear Can Actually Monetize

The idea's core logic — that surging oil, gas and diesel prices strengthen the economic case for nuclear baseload power — is per the Bloomberg piece on the winter energy crisis, and the rotation is already visible: NuScale jumped 15% in a single day per the Yahoo Finance coverage. That is exactly the substitution trade the thesis describes, and it is happening before winter demand hits. There is one genuinely profitable way to own this theme in the basket: Cameco. Its FY2025 results (period ending December 31, 2025) show the margin inflection the nuclear thesis predicts — net margin jumped 11.45 points year over year to 16.9%, gross margin rose 2.91 points to 27.9%, and return on equity more than tripled to 8.5%. Revenue grew 11.0% to $3.48B, free cash flow reached $1.08B (the 94.8th percentile of its materials-sector peers), and the dividend was raised to $0.172 per share for 2025 — up 50.9% from the prior year's $0.114. That is a company whose earnings are already responding to tight uranium and power markets, not just promising to. The basket structure also has a built-in quality gradient. Cameco carries $1.11B of cash against $996M of long-term debt with a current ratio of 2.47. Oklo, for its part, holds $1.25B of current assets against just $25.5M of current liabilities — a current ratio near 49 — so even the pre-revenue names are not balance-sheet-constrained while they build. If the energy squeeze persists, the market has historically been willing to keep funding these stories, and URA gives you 60% top-10 concentration in uranium producers with Cameco at roughly 23% of the fund. The honest framing from the completed backtest: over the evaluated 12-month window the strategy traded twice and lost money overall, but the equity curve shows a profitable stretch mid-window (peaking above +2% before reversing). The entry rules are condition-based pullback-reclaim setups, so whether the current energy backdrop generates fresh, better-timed entries is the live question — not whether the theme has fundamental support, which Cameco's…

Scores

• Conviction score breakdown: 42
• Thesis support: 60
• Trade readiness: 30
• Risk quality: 40
• Backtest evidence: 25
• Fundamentals trend: 55

Watch items

• CCJ — RSI (14)
• CCJ — Close vs 20-day average
• CCJ — Daily low vs lower Bollinger Band (20)
• OKLO — RSI (14)
• OKLO — Close vs 20-day average
• SMR — RSI (14)
• SMR — Close vs 20-day average
• URA — RSI (14)
• URA — Close vs 20-day average
• CCJ — RSI (14)
• OKLO — Insider net open-market activity
• SMR — Insider net open-market activity
• CCJ — Next dividend declaration